Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 12-3 (KRTAP12-3) is a member of the keratin-associated protein (KAP) family, specifically falling within the "high sulfur" group due to its high content of sulfur-rich amino acids such as cysteine. These proteins are primarily expressed in the hair follicle cortex, where they tightly associate with keratin intermediate filaments to contribute to the structure, stability, and properties of hair fibers. KRTAP12-3 is not classified as a receptor, enzyme, transporter, or classic therapeutic target, but rather acts as a structural protein. Defects in keratin-associated proteins can affect hair texture, strength, and appearance, but specific disease associations for KRTAP12-3 have not been documented in the current biomedical literature[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 12-3 (KRTAP12-3).